E-LIB Suche - Ergebnisse für: Stathis, Anastasios

1

Targeting CD19-positive lymphomas with the antibody-drug co..:

Tarantelli, Chiara ; Wald, David ; Munz, Nicolas...
Haematologica. , 2024

2

Tafasitamab for the treatment of patients with diffuse larg..:

Pirosa, Maria Cristina ; Stathis, Anastasios ; Zucca, Emanuele
Human Vaccines & Immunotherapeutics. 20 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

3

IELSG30 phase 2 trial: intravenous and intrathecal CNS prop..:

Conconi, Annarita ; Chiappella, Annalisa ; Ferreri, Andrés J. M....
Blood Advances. 8 (2024) 6 - p. 1541-1549 , 2024

Link: https://doi.org/10.1182/..

4

TLD-1, a novel liposomal doxorubicin, in patients with adva..:

Colombo, Ilaria ; Koster, Kira-Lee ; Holer, Lisa...
European Journal of Cancer. 201 (2024) - p. 113588 , 2024

Link: https://doi.org/10.1016/..

5

IELSG38: phase II trial of front-line chlorambucil plus sub..:

Stathis, Anastasios ; Pirosa, Maria Cristina ; Orsucci, Lorella...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

6

A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patie..:

Hanna, Glenn J. ; Stathis, Anastasios ; Lopez-Miranda, Elena...
Cancer Research Communications. 3 (2023) 9 - p. 1853-1861 , 2023

Link: https://doi.org/10.1158/..

7

P1132: LONG-TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPD..:

Caimi, Paolo F ; Ai, Weiyun Z ; Pablo Alderuccio, Juan...
HemaSphere. 7 (2023) S3 - p. e402511c , 2023

Link: https://doi.org/10.1097/..

8

Loncastuximab tesirine in relapsed/refractory diffuse large..:

Caimi, Paolo F. ; Ai, Weiyun Z. ; Alderuccio, Juan Pablo...
Haematologica. , 2023

Link: https://doi.org/10.3324/..

9

The ATR inhibitor elimusertib exhibits anti‐lymphoma activi..:

Sartori, Giulio ; Tarantelli, Chiara ; Spriano, Filippo...
British Journal of Haematology. 204 (2023) 1 - p. 191-205 , 2023

Link: https://doi.org/10.1111/..

10

How to integrate CD19 specific chimeric antigen receptor T ..:

de Ramon Ortiz, Carmen ; Wang, Sisi ; Stathis, Anastasios...
Hematological Oncology. 42 (2023) 1 - p. , 2023

Link: https://doi.org/10.1002/..

11

Prognostic implication of PD-L1 in early-stage non-small ce..:

Cekani, Elona ; Martorelli, Carolina ; Martucci, Francesco...
Swiss Medical Weekly. 153 (2023) 9 - p. 40110 , 2023

Link: https://doi.org/10.57187..

12

Clinical outcomes of older and younger patients treated wit..:

Hamadani, Mehdi ; Spira, Alexander ; Zhou, Xiaolei...
Blood Advances. 8 (2023) 1 - p. 93-98 , 2023

Link: https://doi.org/10.1182/..

13

Targeting myeloid chemotaxis to reverse prostate cancer the..:

Guo, Christina ; Sharp, Adam ; Gurel, Bora...
Nature. 623 (2023) 7989 - p. 1053-1061 , 2023

Link: https://doi.org/10.1038/..

14

Results of an open-label phase 1b study of the ERK inhibito..:

Stathis, Anastasios ; Tolcher, Anthony W. ; Wang, Judy S....
Investigational New Drugs. 41 (2023) 3 - p. 380-390 , 2023

Link: https://doi.org/10.1007/..

15

Safety and anti-tumor activity of lisavanbulin administered..:

Joerger, Markus ; Hundsberger, Thomas ; Haefliger, Simon...
Investigational New Drugs. 41 (2023) 2 - p. 267-275 , 2023

Link: https://doi.org/10.1007/..